Scope Fluidics

Executive Summary

Scope Fluidics is a Polish biotechnology company specializing in microfluidic-based diagnostic systems. Through its subsidiaries, Curiosity Diagnostics and Bacteromic, it develops rapid point-of-care testing platforms, including the PCR|ONE system for viral and bacterial pathogen detection and the BacterOMIC system for antimicrobial susceptibility testing. The company leverages microfluidics to enable fast, accurate, and portable diagnostics, aiming to address unmet needs in infectious disease diagnosis and antibiotic resistance management. As a private entity in the diagnostics space, Scope Fluidics focuses on advancing its pipeline toward commercialization, with potential for strategic partnerships or licensing deals to accelerate market entry.

Upcoming Catalysts (preview)

• Q4 2026Regulatory submission for PCR|ONE system60% success
• Q2 2026Series B/C funding round to support commercialization70% success